Comet assay studies on the activation of two diaziridinylbenzoquinones in K562 cells

Biochemical Pharmacology

Volumn 53, Issue 8, 1997, Pages 1115-1121

  Ward, Timothy H ^a   Butler, John ^a   Shahbakhti, Hassan ^b   Richards, John T ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SALFORD   (United Kingdom)

Author keywords

aziridinylquinones; AZQ; BZQ; comet; quinones; resistance; SCGE

Indexed keywords

2,5 DIAZIRIDINYL 3,6 BIS(2 HYDROXYETHYLAMINO) 1,4 BENZOQUINONE; DIAZIQUONE;

ARTICLE; DNA CROSS LINKING; DNA DAMAGE; DRUG MECHANISM; DRUG RESISTANCE; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; AZIRIDINES; BENZOQUINONES; CROSS-LINKING REAGENTS; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; ELECTROPHORESIS, AGAR GEL; HUMANS; TUMOR CELLS, CULTURED;

EID: 0030920810     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00818-0     Document Type: Article

References (25)

1. Bender JF, Grillo-Lopez AJ and Posada JG, Diaziquone. Invest New Drugs 1: 71-84, 1983.
2. Schold SC, Friedman HS, Bjornsson TD and Falleta JM, Treatment of patients with recurrent primary brain tumours with AZQ. Neurology 34: 615-619, 1984.
3. Butler J, Dzielendziak A, Lea JS, Ward TH and Hoey BM, Contrasting cytotoxic mechanisms of similar antitumour diaziridinylbenzoquinones. Free Rad Res Comms 8: 231-239, 1990.
4. Szmigiero L and Kohn KW, Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (Diaziquone) in isolated nuclei from human cells. Cancer Res 44: 4453-4457, 1984.
5. Fisher GR, Donis J, and Gutierrez PL, Reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells. II. Enhancement of the alkylating activity of AZQ by NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase). Biochem Pharmacol 44: 1625-1635, 1993.
6. Gibson NW, Hartley JA, Butler J, Siegel D and Ross D, Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity. Mol Pharmacol 42: 531-536, 1992.
7. Hartley JA, Berardini M, Ponti M, Gibson NW, Thompson AS, Thurston DE, Hoey BM and Butler J, DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: A unique reaction at 5′-GC-3′ sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction. Biochemistry 30: 11719-11724, 1991.
8. Butler J, Hoey BM and Ward TH, The alkylation of DNA in vitro by 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinyl-1,4-benzoquinone (BZQ). Biochem Pharmacol 38: 923-7, 1989.
9. Dzielendziak A, Butler J, Hoey BM, Lea JS and Ward TM, Comparison of the structural and cytotoxic activity of novel 2,5 bis(carboethoxyamino)-3,6-diaziridinyl - 1,4-benzoquinone analogues. Cancer Res 50: 2003-2008, 1990.
10. Ward TH, Haran MS, Whittaker D, Watson AJ, Howard TD and Butler J, Cross-resistant studies on two K526 sublines resistant to diaziridinylbenzoquinones. Biochem Pharmacol 50: 459-464, 1995.
11. Ostling O and Johnson J, Microelectrophoretic studies of radiation induced DNA damage in individual mammalian cells. Biochem Biophys Res Commun 123: 291-298, 1984.
12. McKelvey-Martin VJ, Green MH, Schmezer P, Pool-Zobel BL, De-Meo MP and Collins A, The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 288: 47-63, 1993.
13. Collins AR, Fleming IM and Gedik CM, In vitro repair of oxidative and ultraviolet-induced DNA damage in super-coiled nucleoid DNA by human cell extract. Biochim Biophys Acta 1219: 724-727, 1994.
14. Olive PL and Banath JP, Sizing highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent. Exp Cell Res 221: 19-26, 1995.
15. Dzielendziak A and Butler J, 1-4-Benzoquinones: Improved methods of synthesis and new diaziridinyl analogues. Synthesis 643-646, 1989.
16. Chou F-T, Khan AH and Driscoll JS, Potential central nervous system antitumor agents. Aziridinylbenzoquinone. 2. J Med Chem 19: 1302-1307, 1976.
17. Olive PL, Banath JP and Durand RE, Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat Res 122: 86-94, 1990.
18. Garcia ST, McQuillan A and Panasci L, Correlation between the cytotoxicity of melphalan and DNA crosslinks as detected by the ethidium bromide fluorescence assay in the F1 variant of B16 melanoma cells. Biochem Pharmacol 37: 3189-3192, 1988.
19. Butler J, Hoey BM and Lea JS, The reduction of antitumor diaziridinyl benzoquinones. Biochim Biophys Acta 925: 144-149, 1987.
20. Olive PL, Banath JP and Evans HH, Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: Influence of growth kinetics, growth environment and DNA packaging. Br J Cancer 67: 522-530, 1993.
21. Olive PL, Frazer G and Banath JP, Radiation induced apoptosis measured in TK6 human B lymphoblast cells using the comet assay. Radiat Res 136: 130-136, 1993.
22. Butler J and Hoey BM, The one-electron reduction potential of several substrates can be related to their reduction rates by cytochrome P-450 reductase. Biochim Biophys Acta 1161: 72-78, 1993.
23. Butler J and Hoey BM, Redox cycling drugs and DNA damage. In: DNA and Free Radicals (Eds. Halliwell B and Aruoma OI), pp. 243-265. Ellis Horwood, London, 1993.
24. Olive PL and Banath JP, Sizing of highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent. Exp Cell Res 221: 19-26, 1995.
25. Olive PL, Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069. Br J Cancer 71: 537-542, 1995.